We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

This study has suspended participant recruitment.
(Because of approval of Bevacizumab, it was difficult to perform clinical study in 1st line setting.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00316745
First Posted: April 21, 2006
Last Update Posted: November 1, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Hokkaido University Hospital
Information provided by:
Hokkaido Gastrointestinal Cancer Study Group
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: March 2009
  Primary Completion Date: No date given